Management of pain associated with the insertion of intrauterine contraceptives

K Gemzell-Danielsson, D Mansour, C Fiala, A M Kaunitz, L Bahamondes, K Gemzell-Danielsson, D Mansour, C Fiala, A M Kaunitz, L Bahamondes

Abstract

Background: Most intrauterine contraception (IUC) placements do not require pain relief. However, small proportions of nulliparous (∼17%) and parous (∼11%) women experience substantial pain that needs to be proactively managed. This review critically evaluates the evidence for pain management strategies, formulates evidence-based recommendations and identifies data gaps and areas for further research.

Methods: A PubMed literature search was undertaken. Relevant articles on management of pain associated with IUC insertion, published in English between 1980 and November 2012, were identified using the following search terms: 'intrauterine contraception', 'insertion' and 'pain'. RCTs were included; further relevant articles were also identified and included as appropriate.

Results: Seventeen studies were identified and included: 12 RCTs and one non-randomized study of pre-insertion oral analgesia, cervical priming and local anaesthesia; one systematic review and one RCT on post-insertion analgesia and two non-randomized studies on non-pharmacological interventions. There was no conclusive evidence that any prophylactic pharmacological intervention reduces pain associated with IUC insertion. However, most of the regimens studied were adopted from hysteroscopy or abortion and effectiveness in specific subsets of women has not been studied adequately. A systematic review found non-steroidal anti-inflammatory agents (NSAID) to be effective in reactively treating post-insertion pain, but no benefit was found with prophylactic use.

Conclusions: No prophylactic pharmacological intervention has been adequately evaluated to support routine use for pain reduction during or after IUC insertion. Women's anxiety about the procedure may contribute to higher levels of perceived pain, which highlights the importance of counselling, and creating a trustworthy, unhurried and professional atmosphere in which the experience of the provider also has a major role; a situation frequently referred to as 'verbal anaesthesia'.

Keywords: analgesia; cervical priming; intrauterine contraception; local anaesthesia; pain.

References

    1. Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2009:CD007373.
    1. Anon. The reproductive health report: the state of sexual and reproductive health within the European Union. Eur J Contracept Reprod Health Care. 2011;16(Suppl 1):S1–S70.
    1. Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod. 2004;19:81–84. .
    1. Association of Reproductive Health Professionals. 2004. New developments in intrauterine contraception: use of intrauterine contraception in the United States Available at: . (1 November 2011, date last accessed)
    1. Bacon L. Option of local anaesthetic for IUD fittings. J Fam Plann Reprod Health Care. 2011;37:253–254. .
    1. Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception. 2011;84:e11–e16. .
    1. Bailit JL, Love TE, Mercer B. Rising cesarean rates: are patients sicker? Am J Obstet Gynecol. 2004;191:800–803. .
    1. Barber EL, Lundsberg LS, Belanger K, Pettker CM, Funai EF, Illuzzi JL. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol. 2011;118:29–38. .
    1. Brockmeyer A, Kishen M, Webb A. Experience of IUD/IUS insertions and clinical performance in nulliparous women—a pilot study. Eur J Contracept Reprod Health Care. 2008;13:248–254. .
    1. Caliskan E, Filiz T, Yucesoy G, Coskun E, Vural B, Corakci A. Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study. Eur J Contracept Reprod Health Care. 2007;12:372–377. .
    1. Chi IC, Galich LF, Tauber PF, Wilkens LR, Waszak CS, Siemens AJ, Lippes J. Severe pain at interval IUD insertion: a case-control analysis of patient risk factors. Contraception. 1986;34:483–495. .
    1. Chi IC, Wilkens LR, Champion CB, Machemer RE, Rivera R. Insertional pain and other IUD insertion-related rare events for breastfeeding and non-breastfeeding women—a decade's experience in developing countries. Adv Contracept. 1989;5:101–119. .
    1. Chor J, Bregand-White J, Golobof A, Harwood B, Cowett A. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial. Contraception. 2012;85:558–562. .
    1. Cooper NA, Khan KS, Clark TJ. Local anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis. BMJ. 2010;340:c1130. .
    1. Dijkhuizen K, Dekkers OM, Holleboom CA, de Groot CJ, Hellebrekers BW, van Roosmalen GJ, Janssen CA, Helmerhorst FM. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod. 2011;26:323–329. .
    1. Eady A. Local anaesthetic administration for IUD/IUS insertions. J Fam Plann Reprod Health Care. 2011;37:254–255. .
    1. Edelman AB, Schaefer E, Olson A, van Houten L, Bednarek P, Leclair C, Jensen JT. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception. 2011;84:234–239. .
    1. Gemzell-Danielsson K, Cho S, Inki P, Mansour D, Reid R, Bahamondes L. Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling—results of an international survey in 10 countries. Contraception. 2012;86:631–638. .
    1. Goldstuck ND, Ward PJ. Treatment of pain following IUD insertion with meptazinol—a new centrally acting analgesic. Contracept Deliv Syst. 1983;4:33–37.
    1. Gray S. Option of local anaesthetic for IUD fittings. J Fam Plann Reprod Health Care. 2011;37:189–190. .
    1. Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2006:CD006034.
    1. Gupta JK, Johnson N. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix. Lancet. 1990;335:1238–1240. .
    1. Heikinheimo O, Inki P, Kunz M, Parmhed S, Anttila AM, Olsson SE, Hurskainen R, Gemzell-Danielsson K. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception. 2010;81:481–486. .
    1. Hepburn S. Method of local anesthesia for IUD insertion. Contracept Deliv Syst. 1980;1:371–377.
    1. Howard FM. Chronic pelvic pain. Obstet Gynecol. 2003;101:594–611. .
    1. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195:1272–1277. .
    1. Hutt S. Injectable local anaesthesia for IUD/IUS fittings. J Fam Plann Reprod Health Care. 2011a;37:59. .
    1. Hutt S. Women should be routinely offered ILA for IUD fittings. J Fam Plann Reprod Health Care. 2011b;37:253–254. .
    1. Jabir M, Smeet RI. Comparison of oral and vaginal misoprostol for cervical ripening before evacuation of first trimester missed miscarriage. Saudi Med J. 2009;30:82–87.
    1. Jones K. Use of injectable local anaesthesia for IUD/IUS fitting. J Fam Plann Reprod Health Care. 2011;37:253. .
    1. Karabayirli S, Ayrim AA, Muslu B. Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. J Minim Invasive Gynecol. 2012;19:581–584. .
    1. Kurz KH, Meier-oehlke P. Jet injection-local anesthesia for fitting and removal of IUDs. Contracept Deliv Syst. 1983;4:27–32.
    1. Lassner KJ, Chen CH, Kropsch LA, Oberle MW, Lopes IM, Morris L. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil. Bull Pan Am Health Organ. 1995;29:206–215.
    1. Maguire K, Davis A, Rosario TL, Westhoff C. Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception. 2012;86:214–219. .
    1. Marions L, Lövkvist L, Taube A, Johansson M, Dalvik H, Øverlie I. Use of the levonorgestrel releasing-intrauterine system in nulliparous women—a non-interventional study in Sweden. Eur J Contracept Reprod Health Care. 2011;16:126–134. .
    1. McNicholas CP, Madden T, Zhao Q, Secura G, Allsworth JE, Peipert JF. Cervical lidocaine for IUD insertional pain: a randomized controlled trial. Am J Obstet Gynecol. 2012;207:384–386. .
    1. Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol. 2006;108:582–590. .
    1. Mody SK, Kiley J, Rademaker A, Gawron L, Stika C, Hammond C. Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception. 2012;86:704–709. .
    1. Murty J. Use and effectiveness of oral analgesia when fitting an intrauterine device. J Fam Plann Reprod Health Care. 2003;29:150–151. .
    1. Newton JR, Reading AE. The effects of psychological preparation on pain at intrauterine device insertion. Contraception. 1977;16:523–532. .
    1. Oloto EJ, Bromham DR, Murty JA. Pain and discomfort perception at IUD insertion—effect of short-duration, low volume intracervical application of two percent lignocaine gel (Instillagel™)—a preliminary study. Br J Fam Plann. 1996;22:177–180.
    1. Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, Secura G. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105–1113. .
    1. Sääv I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007;22:2647–2652. .
    1. Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010;203:115.e1–115.e7.
    1. Singh K, Fong YF, Prasad RN, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol. 1998;92:795–798. .
    1. Singh K, Fong YF, Prasad RN, Dong F. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming? Hum Reprod. 1999a;14:1635–1637. .
    1. Singh K, Fong YF, Prasad RN, Dong F. Evacuation interval after vaginal misoprostol for preabortion cervical priming: a randomized trial. Obstet Gynecol. 1999b;94:431–434. .
    1. Singh K, Fong YF, Prasad RN, Dong F. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval? Br J Obstet Gynaecol. 1999c;106:266–269. .
    1. Stavrou EP, Ford JB, Shand AW, Morris JM, Roberts CL. Epidemiology and trends for Caesarean section births in New South Wales, Australia: a population-based study. BMC Pregnancy Childbirth. 2011;11:8. .
    1. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception. 2004;69:407–412. .
    1. Swenson C, Turok DK, Ward K, Jacobson JC, Dermish A. Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstet Gynecol. 2012;120:341–347. .
    1. Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99(Suppl 2):S160–S167. .
    1. Thiery M. Pain relief at insertion and removal of an IUD: a simplified technique for paracervical block. Adv Contracept. 1985;1:167–170. .
    1. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397–404. .
    1. Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, Velazco A, Shah A, Campodónico L, Bataglia V, Faundes A, et al. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet. 2006;367:1819–1829. .
    1. Ward K, Jacobson JC, Turok DK, Murphy PA. A survey of provider experience with misoprostol to facilitate intrauterine device insertion in nulliparous women. Contraception. 2011;84:594–599. .
    1. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007. .

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다